bioRxiv · 10.1101/339614
Revealing heterogeneity of brain imaging phenotypes in Alzheimer’s disease based on unsupervised clustering of blood marker profiles
Abstract
Alzheimers disease (AD) affects millions of people and is a major rising problem in health care worldwide. Recent research suggests that AD could have different subtypes, presenting differences in how the disease develops. Characterizing those subtypes could be key to deepen the understanding of this complex disease. In this paper, we used a multivariate, non-supervised clustering method over blood-based markers to find subgroups of patients defined by distinctive blood marker profiles. Our analysis on ADNI database identified 4 possible subgroups, each with a different blood profile. More importantly, we show that subgroups with different profiles have a different relationship between brain phenotypes detected in magnetic resonance imaging and disease condition.
Source connections
Explore related subjects
Keep this discovery
Marti-Juan, G., Sanroma, G., Piella, G., The Alzheimers Disease Neuroimaging Initiative and the Alzheimers Disease Metabolomics,. 2018-06-05. Revealing heterogeneity of brain imaging phenotypes in Alzheimer’s disease based on unsupervised clustering of blood marker profiles. https://doi.org/10.1101/339614
Cite the original work for its findings. Save a collection to share your selection of sources.